相关实验视频
Updated: Feb 28, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.3K
关于应对先天性心脏病的父母对父母的建议:一种混合方法研究
Katharine Press Callahan1,2, Rebecca Dorner3, Magdalena Jaworski4
1The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA callahankp@chop.edu.
Archives of disease in childhood
|February 26, 2026
概括
父母为先天性心脏病 (CHD) 诊断提供指导,强调通过信息,自我照顾,信任和积极的前景赋权. 这些见解可以改善临床医生支持和患者计划.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 家长支持系统
- 健康心理学 心理健康心理学
背景情况:
- 遗传性心脏病 (CHD) 给家庭带来了重大挑战.
- 有效的家长支持对于导航心脏病诊断至关重要.
- 通过了解父母的经历,可以加强临床咨询.
研究的目的:
- 系统地分析对先天性心脏病 (CHD) 新诊断的父母对父母的指导.
- 为患有心血管疾病的家庭提供临床医师咨询策略.
- 为心血管疾病患者和家属提供增强支持计划的制定提供指导.
主要方法:
- 采访了100名患有心脏病需要手术或导管治疗的儿童的父母.
- 对家长建议的混合方法分析.
- 定性主题分析和与社会/临床因素的定量相关性.
主要成果:
- 主要的家长建议包括通过信息和支持赋予自己权力 (50%),自我照顾 (23%),信任医疗团队和孩子 (31%),并保持积极性 (42%).
- 父母建议平衡控制与适应不确定性.
- 建议在社会或临床因素之间显示出最小的差异.
结论:
- 父母推为新诊断出心血管疾病的家庭提供实用建议.
- 这些见解为临床医生提供了可行的步骤,以支持家庭.
- 临床医生应该为父母提供信息,促进对控制的反思,并促进与其他父母的联系.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
568
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
568
Cardiomyopathy V: Interprofessional Care
542
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
542
Mitral Regurgitation IV: Nursing Management
436
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
436
Rheumatic Heart Disease IV: Nursing Management
386
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
386
Mitral Stenosis IV: Nursing Management
327
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
327
Heart Failure VI: Adjunct Therapies
466
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
466

